Tesamorelin is listed for professional research use with an emphasis on documentation, compound identification, research applications, storage awareness, and third-party testing transparency
The decision to prescribe medication is made with careful consideration, aiming to support each patient's journey towards achieving and maintaining a healthy weight
Were not going to oversell it its still investigational, its not approved, and anyone telling you otherwise is getting ahead of the evidence
What This Program Is NOT
Patients on both medications may experience more pronounced early appetite suppression due to the combined effect, but this does not necessarily translate to faster weight loss if caloric intake drops too low, as severe restriction can slow metabolic rate
doi: 10.1038/nature18928 131 HayesL